Schedule 13G ownership disclosure

SUNSHINE BIOPHARMA INC

Security class unavailable · CUSIP: 867781403

Event date: 2022-10-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
16.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001683168-22-007203
Form type
SC 13G
Filer
Chamoun Malek
CIK
CIK 1951769
Filed
Nov 02, 2022
Reporting period
Oct 20, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub